TGFB2 and triple-negative breast carcinoma: It is shown that SRGN, due to its interaction with CD44, creates a positive loop with TGFβ2, regulating cellular migration, invasion, EMT and metastasis of the triple-negative breast cancer cell line MDA-MB-231 [28].